Recruiting

Study of Crizanlizumab for Prevention of Silent Cerebral Infarcts in SCA

Sponsor:

Andria Ford

Code:

NCT05334576

Conditions

Sickle Cell Disease

Eligibility Criteria

Sex: All

Age: 16+

Healthy Volunteers: Not accepted

Interventions

Crizanlizumab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information